Type I Interferon Signals in Macrophages and Dendritic Cells Control Dengue Virus Infection: Implications for a New Mouse Model To Test Dengue Vaccines

The global distribution and burden of dengue

(2013) Samir Bhatt et al.   NATURE

Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate

(2013) Raphaël M. Zellweger et al.   PLoS Pathogens

Rational Design of a Live Attenuated Dengue Vaccine: 2′-O-Methyltransferase Mutants Are Highly Attenuated and Immunogenic in Mice and Macaques

(2013) Roland Züst et al.   PLoS Pathogens

Resistance analysis of an antibody that selectively inhibits dengue virus serotype-1

(2012) Gang Zou et al.   ANTIVIRAL RESEARCH

Purified and highly aggregated chimeric protein DIIIC-2 induces a functional immune response in mice against dengue 2 virus

(2012) Ernesto Marcos et al.   ARCHIVES OF VIROLOGY

Characterization of a model of lethal dengue virus 2 infection in C57BL/6 mice deficient in the alpha/beta interferon receptor

(2012) S. Orozco et al.   JOURNAL OF GENERAL VIROLOGY

Plasmablasts Generated during Repeated Dengue Infection Are Virus Glycoprotein-Specific and Bind to Multiple Virus Serotypes

(2012) M. Xu et al.   JOURNAL OF IMMUNOLOGY

Gamma Interferon (IFN- ) Receptor Restricts Systemic Dengue Virus Replication and Prevents Paralysis in IFN- /  Receptor-Deficient Mice

(2012) T. R. Prestwood et al.   JOURNAL OF VIROLOGY

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

(2012) Arunee Sabchareon et al.   LANCET

Dengue

(2012) Cameron P. Simmons et al.   NEW ENGLAND JOURNAL OF MEDICINE

Animal Models of Dengue Virus Infection

(2012) Simona Zompi et al.   Viruses-Basel

A Single Amino Acid in Nonstructural Protein NS4B Confers Virulence to Dengue Virus in AG129 Mice through Enhancement of Viral RNA Synthesis

(2011) D. Grant et al.   JOURNAL OF VIROLOGY

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness

(2011) V.J. Gunther et al.   VACCINE

Mouse STAT2 Restricts Early Dengue Virus Replication

(2010) Joseph Ashour et al.   Cell Host & Microbe

Concomitant type I IFN receptor-triggering of T cells and of DC is required to promote maximal modified vaccinia virus Ankara-induced T-cell expansion

(2010) Theresa Frenz et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Dengue: a continuing global threat

(2010) Maria G. Guzman et al.   NATURE REVIEWS MICROBIOLOGY

A Non Mouse-Adapted Dengue Virus Strain as a New Model of Severe Dengue Infection in AG129 Mice

(2010) Grace K. Tan et al.   PLoS Neglected Tropical Diseases

Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification

(2010) Scott J. Balsitis et al.   PLoS Pathogens

Levels of soluble ST2 in serum associated with severity of dengue due to tumour necrosis factor alpha stimulation

(2009) N. Houghton-Trivino et al.   JOURNAL OF GENERAL VIROLOGY

A Protective Role for Dengue Virus-Specific CD8+ T Cells

(2009) L. E. Yauch et al.   JOURNAL OF IMMUNOLOGY

An adenosine nucleoside inhibitor of dengue virus

(2009) Z. Yin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A novel fusion protein domain III-capsid from dengue-2, in a highly aggregated form, induces a functional immune response and protection in mice

(2009) Iris Valdés et al.   VIROLOGY

Development of real time PCR for detection and quantitation of dengue viruses

(2009) K R Gurukumar et al.   Virology Journal

Enhancement by Tumor Necrosis Factor Alpha of Dengue Virus-Induced Endothelial Cell Production of Reactive Nitrogen and Oxygen Species Is Key to Hemorrhage Development

(2008) Y.-T. Yen et al.   JOURNAL OF VIROLOGY